Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 10/20 | 0.56 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27845477 | 0.98 | EPHX2 (0.54) | EPHX2FAAHP2RX7MAPK1EPHX1 | |
| SCHEMBL1397748 | 0.90 | EPHX2 (0.47) | EPHX2FAAHP2RX7MAPK1EPHX1 | |
| SCHEMBL28205291 | 0.88 | EPHX2 (0.49) | EPHX2FAAHP2RX7MAPK1EPHX1 | |
| SCHEMBL7980459 | 0.79 | EPHX2 (0.58) | EPHX2P2RX7EPHX1ALDH1A1TSHR | |
| SCHEMBL11447009 | 0.79 | POLB (0.53) | EPHX2ALDH1A1TSHRHTTHSD17B10 | |
| SCHEMBL11152183 | 0.79 | EPHX2 (0.53) | EPHX2FAAHP2RX7MAPK1EPHX1 | |
| Hydrochloric Acid SCHEMBL11156286 | 0.78 | EPHX2 (0.51) | EPHX2FAAHP2RX7MAPK1EPHX1 | |
| SCHEMBL22441207 | 0.77 | EPHX2 (0.68) | EPHX2FAAHEPHX1 | |
| SCHEMBL7979165 | 0.77 | EPHX2 (0.62) | EPHX2P2RX7MAPK1EPHX1TSHR | |
| SCHEMBL30208695 | 0.77 | ALDH1A1 (0.43) | EPHX2FAAHALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118064421-A | Covalent organic framework material immobilized biocatalyst and preparation method and application thereof | 南开大学 | 2024-05-24 | — | — | CN | claimed |
| CN-117143387-A | Covalent organic framework material with structural color and preparation method thereof | 中山大学 | 2023-12-01 | — | — | CN | claimed |
| CN-109897190-B | N-heterocyclic carbene functionalized covalent organic framework material and synthesis method thereof | 山西师范大学 | 2021-07-30 | — | — | CN | claimed |
| CN-108117513-B | Three-dimensional bipyridyl functionalized organic porous material and synthesis method and application thereof | 中国科学院大连化学物理研究所 | 2020-08-21 | — | — | CN | claimed |
| CN-107915658-B | Three-dimensional covalent organic framework material based on adamantane unit and synthesis and application thereof | 中国科学院大连化学物理研究所 | 2020-04-21 | — | — | CN | claimed |
| CN-108117537-B | Three-dimensional covalent organic framework material based on tetrathiafulvalene unit and synthetic method | 中国科学院大连化学物理研究所 | 2020-03-31 | — | — | CN | claimed |
| CN-110894321-A | Preparation method of mildew-proof bamboo-plastic composite material | 安徽霖园外新材料有限公司 | 2020-03-20 | — | — | CN | claimed |
| CN-108117646-B | A kind of three-dimensional polyimides covalence organic porous material and its preparation method and application | 中国科学院大连化学物理研究所 | 2019-11-08 | — | — | CN | claimed |
| CN-120483884-A | Adamantyl aniline derivative and preparation method thereof | 甘肃省天之河科技化工有限公司 | 2025-08-15 | — | — | CN | disclosed |
| CN-120483884-A | Adamantyl aniline derivative and preparation method thereof | 甘肃省天之河科技化工有限公司 | 2025-08-15 | — | — | CN | disclosed |
| CN-118344545-A | Triphenylamine-based three-dimensional covalent organic framework material and preparation method and application thereof | 安徽大学 | 2024-07-16 | — | — | CN | disclosed |
| CN-118064421-A | Covalent organic framework material immobilized biocatalyst and preparation method and application thereof | 南开大学 | 2024-05-24 | — | — | CN | disclosed |
| CN-117430766-A | Biological composite material based on covalent organic framework materials (COFs), preparation and application thereof | 南开大学 | 2024-01-23 | — | — | CN | disclosed |
| CN-117143387-A | Covalent organic framework material with structural color and preparation method thereof | 中山大学 | 2023-12-01 | — | — | CN | disclosed |
| US-20120059182-A1 | Catalysts, Methods of Makting Catalysts, and Methods of Use | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2012-03-08 | — | — | US | disclosed |
| US-20110201665-A1 | Compositions, Methods, and Kits for Treating Influenza Viral Infections | COMBINATORX (SINGAPORE) PTE. LTD. (SG) | 2011-08-18 | — | — | US | disclosed |
| US-20110028510-A1 | Compositions, Methods, and Kits for Treating Influenza Viral Infections | COMBINATORX (SINGAPORE) PTE. LTD. (SG) | 2011-02-03 | — | — | US | disclosed |
| EP-0810223-B1 | Adamantyl substituted oxindoles as pharmaceutical agents | PFIZER (US) | 2001-07-25 | — | — | EP | disclosed |
| US-5948781-A | Adamantyl substituted oxindoles as pharmaceutical agents | PFIZER INC (US) | 1999-09-07 | — | — | US | disclosed |
| EP-0810223-A1 | Adamantyl substituted oxindoles as pharmaceutical agents | PFIZER INC. (US) | 1997-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059182-A1 | Catalysts, Methods of Makting Catalysts, and Methods of Use | DKC1, ADCK1, AMD1 | EPHX2 1830/4885FAAH 1790/4885P2RX7 4847/4885 |
| US-20110201665-A1 | Compositions, Methods, and Kits for Treating Influenza Viral Infections | IL5, CCL5, CCL11 | EPHX2 1373/4885FAAH 1963/4885P2RX7 99/4885 |
| US-20110028510-A1 | Compositions, Methods, and Kits for Treating Influenza Viral Infections | IL5, CCL5, CCL11 | EPHX2 1373/4885FAAH 1963/4885P2RX7 99/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.